Literature DB >> 974391

Comparative studies on the effects of metoclopramide and some known neuroleptics on the EEG of the conscious rat [proceedings].

M G Baxter, A A Miller, P L Wheatley.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 974391      PMCID: PMC1667309     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  7 in total

1.  Proceedings: Combined EEG recording and intraventricular administration of drugs in the conscious rat.

Authors:  D Goff; A A Miller; R E Smith; S J Smith; P L Wheatley
Journal:  Br J Pharmacol       Date:  1975-10       Impact factor: 8.739

2.  Effect of metoclopramide on turnover of brain dopamine noradrenaline and 5-hydroxytryptamine.

Authors:  E Peringer; P Jenner; C D Marsden
Journal:  J Pharm Pharmacol       Date:  1975-06       Impact factor: 3.765

3.  Receptor activity and turnover of dopamine and noradrenaline after neuroleptics.

Authors:  N E Andén; S G Butcher; H Corrodi; K Fuxe; U Ungerstedt
Journal:  Eur J Pharmacol       Date:  1970       Impact factor: 4.432

4.  [Clinical and electroencephalographic effects of methoclopramide in psychiatry].

Authors:  P Borenstein; G Bles
Journal:  Therapie       Date:  1965 Jul-Aug       Impact factor: 2.070

5.  Inhibition by apomorphine of the metoclopramide-induced catalepsy and increase in striatal homovanillic acid content.

Authors:  L Ahtee
Journal:  Br J Pharmacol       Date:  1975-11       Impact factor: 8.739

6.  Pharmacological evidence for cerebral dopamine receptor blockade by metoclopramide in rodents.

Authors:  A Dolphin; P Jenner; C D Marsden; C Pycock; D Tarsy
Journal:  Psychopharmacologia       Date:  1975

7.  A neuronal basis for the alerting action of (+)-amphetamine.

Authors:  R J Boakes; P B Bradley; J M Candy
Journal:  Br J Pharmacol       Date:  1972-07       Impact factor: 8.739

  7 in total
  2 in total

1.  Dexamphetamine-induced EEG arousal in rats: a possible new test model for potential anti-schizophrenic agents [proceedings].

Authors:  M G Baxter; A A Miller; P L Wheatley
Journal:  Br J Pharmacol       Date:  1978-11       Impact factor: 8.739

2.  The involvement of dopamine in the central actions of bupropion, a new antidepressant [proceedings].

Authors:  H Canning; D Goff; M J Leach; A A Miller; J E Tateson; P L Wheatley
Journal:  Br J Pharmacol       Date:  1979-05       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.